Opportunity Information: Apply for CDC RFA DP13 1311
Apply for CDC RFA DP13 1311
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Standardizing Electronic Laboratory and Biomarker Reporting" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on May 15, 2013 and posted on May 15, 2013.
- Applicants must submit their applications by Jun 17, 2013 Dates Optional Letter of Intent Deadline Date May 20, 2013 1159 p.m. U.S. Eastern Standard Time Application Deadline Date June 17, 2013, 1159 p.m. U.S. Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,250,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- American Indian/Alaska Native tribal governments (federally recognized or state recognized) American Indian/Alaska native tribally designated organizations Alaska Native health corporations Colleges Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Political subdivisions of States (in consultation with States) Research institutions (that will perform activities deemed as non research) Small, minority, and women owned businesses State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Tribal epidemiology centers Universities Urban Indian health organizations A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled Standardizing Electronic Laboratory and Biomarker Reporting (Funding Opportunity Number: CDC RFA DP13-1311) was a CDC discretionary funding announcement that used a cooperative agreement mechanism. Its core purpose was to strengthen cancer surveillance by improving how laboratory information is electronically reported to central cancer registries, with a strong emphasis on coordinating efforts across agencies, laboratories, registry programs, and other partners. The announcement framed standardized, electronic laboratory reporting as a practical requirement for more complete, timely, and usable cancer data, especially as biomarker and molecular testing became increasingly important for diagnosis, treatment decisions, and population-level monitoring.
The work described in the announcement focused on three closely related aims. First, it sought to facilitate the development of standards for electronic reporting to central cancer registries from both clinical laboratories and anatomic pathology laboratories. In plain terms, the intent was to move beyond ad hoc, inconsistent reporting and toward shared technical and content standards so that registry systems could reliably ingest, interpret, and use lab information without extensive manual rework. Second, it prioritized identifying and documenting barriers and solutions related to accurately capturing data contained in biomarker and molecular tests. This reflects a common real-world challenge: biomarker results are often embedded in complex narrative reports, vary widely by lab and platform, and may be formatted in ways that are difficult to extract and code consistently. The CDC was effectively looking for structured approaches to pinpoint where the breakdowns occur (for example, inconsistent terminology, missing discrete fields, mismatched identifiers, or workflow and interoperability issues) and to propose workable fixes. Third, the opportunity aimed to promote expansion of electronic reporting from laboratories to central cancer registries, meaning the effort was not just about creating or refining standards on paper, but also about driving broader adoption and scaling electronic reporting practices in ways that would increase coverage and completeness of registry data.
Administratively, the CDC listed this opportunity under CFDA 93.283 (Investigations and Technical Assistance). The total estimated funding was $1,250,000, with an award ceiling of $250,000, and the CDC expected to make one award. There was no cost sharing or matching requirement, which typically lowers barriers to participation for eligible entities. Key dates show it was posted May 15, 2013, with an optional letter of intent due May 20, 2013, and a full application deadline of June 17, 2013 at 11:59 p.m. U.S. Eastern Time. The opportunity was later archived on July 17, 2013.
Eligibility was broad and included many public and private entities that could plausibly convene partners and implement technical reporting improvements. Eligible applicants included state and local governments (and their bona fide agents), territorial governments, tribal governments and tribal organizations, tribal epidemiology centers, Alaska Native health corporations, universities and colleges, hospitals, research institutions (for activities deemed non-research), community-based and faith-based organizations, and for-profit organizations (other than small businesses), including small, minority-, and women-owned businesses. The announcement also clarified the bona fide agent concept: if applying on behalf of a state or local government, the applicant had to provide a legal, binding agreement documenting that status.
Because this was a cooperative agreement rather than a standard grant, the structure implied a more active partnership with CDC during execution. In practice, that typically means CDC technical input and coordination expectations are higher, and deliverables are shaped to support national surveillance needs and interoperability goals. The overall thrust of the funding announcement was to make laboratory and biomarker reporting more standardized, more electronic, and more scalable, so central cancer registries could better support cancer surveillance with higher-quality, more complete laboratory-derived data.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled Standardizing Electronic Laboratory and Biomarker Reporting.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DP13-1311.
Which agency offered this opportunity?
This was a Centers for Disease Control and Prevention (CDC) discretionary funding announcement.
What funding mechanism was used (grant vs. cooperative agreement)?
The announcement used a cooperative agreement mechanism rather than a standard grant.
What does it mean that this was a cooperative agreement?
Because it was a cooperative agreement, the structure implied a more active partnership with CDC during execution, including higher expectations for CDC technical input and coordination, and deliverables shaped to support national surveillance and interoperability goals.
What was the main purpose of this opportunity?
The core purpose was to strengthen cancer surveillance by improving how laboratory information is electronically reported to central cancer registries, with a strong emphasis on coordination across agencies, laboratories, registry programs, and other partners.
Why did the announcement emphasize standardized electronic laboratory reporting?
The announcement framed standardized, electronic laboratory reporting as a practical requirement for producing cancer data that is more complete, timely, and usable, especially as biomarker and molecular testing became increasingly important for diagnosis, treatment decisions, and population-level monitoring.
What were the main aims or focus areas described in the announcement?
The work focused on three closely related aims:
- Facilitate the development of standards for electronic reporting to central cancer registries from clinical laboratories and anatomic pathology laboratories.
- Identify and document barriers and solutions to accurately capturing data contained in biomarker and molecular tests.
- Promote expansion of electronic reporting from laboratories to central cancer registries to drive broader adoption and scaling.
What kinds of laboratories were specifically mentioned?
The announcement explicitly referenced both clinical laboratories and anatomic pathology laboratories as sources of electronic reporting to central cancer registries.
What types of data challenges did the opportunity highlight for biomarkers and molecular tests?
It highlighted that biomarker results are often embedded in complex narrative reports, vary by lab and platform, and may be formatted in ways that are difficult to extract and code consistently. Examples of breakdowns mentioned include inconsistent terminology, missing discrete fields, mismatched identifiers, and workflow or interoperability issues.
Was the opportunity only about developing standards on paper?
No. In addition to facilitating standards development and addressing barriers, the opportunity aimed to promote expanded adoption and scaling of electronic reporting from laboratories to central cancer registries.
What was the CFDA number associated with this opportunity?
The opportunity was listed under CFDA 93.283 (Investigations and Technical Assistance).
What was the total estimated funding amount?
The total estimated funding was $1,250,000.
What was the award ceiling?
The award ceiling was $250,000.
How many awards did CDC expect to make?
CDC expected to make one award.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement.
When was the opportunity posted?
The opportunity was posted on May 15, 2013.
Was a letter of intent required?
A letter of intent was optional.
When was the optional letter of intent due?
The optional letter of intent was due on May 20, 2013.
What was the application deadline?
The full application deadline was June 17, 2013 at 11:59 p.m. U.S. Eastern Time.
Was this funding opportunity later archived?
Yes. The opportunity was archived on July 17, 2013.
Who was eligible to apply?
Eligibility was broad and included many public and private entities, including:
- State and local governments (and their bona fide agents)
- Territorial governments
- Tribal governments and tribal organizations
- Tribal epidemiology centers
- Alaska Native health corporations
- Universities and colleges
- Hospitals
- Research institutions (for activities deemed non-research)
- Community-based and faith-based organizations
- For-profit organizations (other than small businesses), including small, minority-, and women-owned businesses
What is a "bona fide agent" in the context of eligibility?
The announcement clarified that if an applicant was applying on behalf of a state or local government as a bona fide agent, the applicant needed to provide a legal, binding agreement documenting that status.
Did the opportunity mention any special emphasis on coordination or partnerships?
Yes. A major emphasis was on coordinating efforts across agencies, laboratories, registry programs, and other partners to improve electronic reporting and standardization.
What was the overall expected impact on cancer surveillance?
The overall thrust was to make laboratory and biomarker reporting more standardized, more electronic, and more scalable so that central cancer registries could support cancer surveillance with higher-quality, more complete laboratory-derived data.
Browse more opportunities from the same category: Health
Next opportunity: VA Grant and Per Diem Program FY13 Rehabilitation NOFA
Previous opportunity: Sustain Our Great Lakes Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP13 1311
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP13 1311) also looked into and applied for these:
| Funding Opportunity |
|---|
| Evidence based Demonstration Projects in Immunization (Admin Supp) Apply for PA 13 226 Funding Number: PA 13 226 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Minority Serving Institutions (MSIs) Partnerships with Community Based Organizations (CBOs). (Short Title MSI/CBO) Apply for SP 13 006 Funding Number: SP 13 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Rural Access to Emergency Devices Grant Program Apply for HRSA 13 280 Funding Number: HRSA 13 280 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome Apply for CDC RFA DD13 1302 Funding Number: CDC RFA DD13 1302 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral Microbiota (R01) Apply for RFA DE 14 003 Funding Number: RFA DE 14 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building and Supporting Core Public Health Capacities Related to Violence and Injury Prevention Apply for CDC RFA CE13 1307 Funding Number: CDC RFA CE13 1307 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Children s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 14 010 Funding Number: HRSA 14 010 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| HEALTH SYSTEMS STRENGTHENING, QUALITY IMPROVEMENT, AND RMNCH A SCALE UP Apply for APS 386 13 000006 Funding Number: APS 386 13 000006 Agency: India USAID New Delhi Category: Health Funding Amount: $74,000,000 |
| Social Health Protection Project Apply for RFA 442 13 000002 Funding Number: RFA 442 13 000002 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $14,000,000 |
| Health Information Policy and Advocacy Project Apply for RFA 442 13 000003 Funding Number: RFA 442 13 000003 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $5,000,000 |
| National Support to Enhance Implementation of Comprehensive Cancer Control Activities Apply for CDC RFA DP13 1315 Funding Number: CDC RFA DP13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Using New Media to Prevent Substance Abuse and HIV/AIDS for Populations at High Risk (Short Title SA HIV/AIDS Prevention New Media) Apply for SP 13 008 Funding Number: SP 13 008 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Safe Schools/Healthy Students State Planning, Local Education Agency, and Local Community Cooperative Agreements, (Short Title SS/HS State Program) Apply for SM 13 006 Funding Number: SM 13 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,214,000 |
| National Resource Center for Mental Health Promotion and Youth Violence Prevention (Short Title YVP RC) Apply for SM 13 007 Funding Number: SM 13 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,171,000 |
| Consortium of National Networks to Impact Tobacco Related and Cancer Health Disparities Apply for CDC RFA DP13 1314 Funding Number: CDC RFA DP13 1314 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $725,000 |
| Services Research for Autism Spectrum Disorder across the Lifespan (ServASD) Pilot Research on Services for Transition Age Youth (R34) Apply for RFA MH 14 101 Funding Number: RFA MH 14 101 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Services Research for Autism Spectrum Disorder across the Lifespan (ServASD) Research on Early Identification and Linkage to Services for ASD (R01) Apply for RFA MH 14 100 Funding Number: RFA MH 14 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Services Research for Autism Spectrum Disorders across the Lifespan (ServASD) Pilot Studies of Services Strategies for Adults with ASD (R34) Apply for RFA MH 14 102 Funding Number: RFA MH 14 102 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI)(R21) Apply for PA 13 237 Funding Number: PA 13 237 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) Apply for PA 13 236 Funding Number: PA 13 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP13 1311", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.